Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Huma
company
About
Huma provides a digital health platform used for predictive care and research.
- 101 - 250
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $25M
- Industries
- Health Care,Information Technology,mHealth
- Founded date
- Aug 2, 2011
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Huma is a global health technology company that provides a modular platform to support digital 'hospitals at home' across different disease areas. Its platform combines predictive algorithms, digital biomarkers, and real-world data to advance proactive, predictive care and research.The company was founded in 2011 and is headquartered in London, England.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$155M £25M
Huma has raised a total of
$155M £25M
in funding over 2 rounds. Their latest funding was raised on
Mar 23, 2022 from a Corporate Round round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 23, 2022 | Corporate Round | £25M | 1 |
AstraZeneca
|
— | Detail |
| May 11, 2021 | Series C | $130M | 1 | — | — | Detail |
| Nov 5, 2019 | Series B | $25M | 1 |
Bayer
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
3
Huma is funded by 3 investors.
AstraZeneca
and Bayer
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
AstraZeneca
|
Yes | Corporate Round |
|
Bayer
|
Yes | Series B |
HAT Technology & Innovation Fund
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
